Sigma Pharmaceuticals keeps sliding: down 7.8% in 3 days Sigma Pharmaceuticals Limited, Australia's 4th largest pharmaceuticals, biotechnology & life sciences company by market capitalisation, extended its slide Tuesday, shedding an additional 2.30c (or 4.1%) to close at 53.20c. The shares have tumbled 4.50c (or 7.8%) over the past three trading days. Compared with the All Ordinaries Index which fell 83.9 points (or 1.6%) in the three days, this represented a relative price change of -6.2%.
We are currently bullish on this stock in the longterm based on fundamental metrics, but are more bearish in the short-term based on technical indicators What makes us most bullish on the stock is the following: Price/Earnings of 32.1 versus sector average of 33.2 and market average of 27.3. • "A dividend yield of at least two-thirds the triple-A bond yield"; the stock's dividend yield is 1.2 times the tripe-A bond yield of 3.1%. • "Current ratio of two or more"; current assets are 2.1 times current liabilities.
SIP Price at posting:
50.7¢ Sentiment: Hold Disclosure: Held
